JP2013147495A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013147495A5 JP2013147495A5 JP2012276866A JP2012276866A JP2013147495A5 JP 2013147495 A5 JP2013147495 A5 JP 2013147495A5 JP 2012276866 A JP2012276866 A JP 2012276866A JP 2012276866 A JP2012276866 A JP 2012276866A JP 2013147495 A5 JP2013147495 A5 JP 2013147495A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- amino acid
- acid sequence
- polypeptide represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 208000027866 inflammatory disease Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 208000035473 Communicable disease Diseases 0.000 claims 2
- 206010047115 Vasculitis Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012276866A JP6120133B2 (ja) | 2011-12-19 | 2012-12-19 | 人工ポリクローナル免疫グロブリン組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011277163 | 2011-12-19 | ||
| JP2011277163 | 2011-12-19 | ||
| JP2012276866A JP6120133B2 (ja) | 2011-12-19 | 2012-12-19 | 人工ポリクローナル免疫グロブリン組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013147495A JP2013147495A (ja) | 2013-08-01 |
| JP2013147495A5 true JP2013147495A5 (cg-RX-API-DMAC7.html) | 2016-02-12 |
| JP6120133B2 JP6120133B2 (ja) | 2017-04-26 |
Family
ID=48654789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012276866A Active JP6120133B2 (ja) | 2011-12-19 | 2012-12-19 | 人工ポリクローナル免疫グロブリン組成物 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US10208131B2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6120133B2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10196457B2 (en) | 2011-12-19 | 2019-02-05 | National University Corporation Chiba University | Artificial immunoglobulin fragment composition |
| JP6670129B2 (ja) * | 2015-02-27 | 2020-03-18 | 国立大学法人千葉大学 | 人工免疫グロブリン断片組成物 |
| AU2018213716B2 (en) * | 2017-01-27 | 2025-01-30 | A-Clip Institute, Co. ltd. | Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease |
| CN119317838A (zh) * | 2022-06-30 | 2025-01-14 | 株式会社Ａ－Ｃｌｉｐ研究所 | 检查血管炎的罹患状态或covid-19的重症化风险的方法、检查用试剂盒、伴随诊断试剂以及检查用标记物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4392375B2 (ja) | 2004-03-31 | 2009-12-24 | 積水化学工業株式会社 | 人工ポリクローナル免疫グロブリンの製造方法、並びに、免疫グロブリン製剤の製造方法 |
| US20050260710A1 (en) * | 2004-03-31 | 2005-11-24 | Sekisui Chemical Co. Ltd. | Methods for producing recombinant polyclonal immunoglobulins |
-
2012
- 2012-12-17 US US13/716,469 patent/US10208131B2/en active Active
- 2012-12-19 JP JP2012276866A patent/JP6120133B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013520405A5 (cg-RX-API-DMAC7.html) | ||
| JP2011250797A5 (cg-RX-API-DMAC7.html) | ||
| EA201490809A1 (ru) | Способы и композиции для лечения неэффективного эритропоэза | |
| MY174772A (en) | Human antibodies to respiratory syncytial virus f protein and methods of use thereof | |
| JP2012115277A5 (cg-RX-API-DMAC7.html) | ||
| JP2013542919A5 (cg-RX-API-DMAC7.html) | ||
| JP2015517488A5 (cg-RX-API-DMAC7.html) | ||
| EA201270575A1 (ru) | Соединения | |
| EA201491155A1 (ru) | Новые мутантные про-нрф и их применение для получения бета-нрф | |
| JP2013539454A5 (cg-RX-API-DMAC7.html) | ||
| NZ606765A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| EA201792597A3 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
| JP2013531993A5 (cg-RX-API-DMAC7.html) | ||
| RU2015119523A (ru) | Новый способ лечения повреждения спинного мозга с применением фрагмента hmgb1 | |
| EA201300132A1 (ru) | Фармацевтическая композиция и методы лечения и профилактики заболеваний, вызванных вич или ассоциированных с вич | |
| MX2010007670A (es) | Uso de sal de acido acetilsalicilico para tratamiento de infecciones virales. | |
| JP2013147495A5 (cg-RX-API-DMAC7.html) | ||
| JP2013531491A5 (cg-RX-API-DMAC7.html) | ||
| EA201391026A1 (ru) | Кристаллическое производное оксазина и его применение в качестве ингибитора bace | |
| EA201591704A1 (ru) | Новые устойчивые соли пентадекапептида, способ их получения, их применение в производстве фармацевтических составов и их применение в терапии | |
| NZ629964A (en) | Method for treating inflammation | |
| JP2013504519A5 (cg-RX-API-DMAC7.html) | ||
| WO2011045573A3 (en) | Staphylococcal antigens | |
| EA201592298A1 (ru) | Полуживая вирусная вакцина против респираторно-синцитиального вируса | |
| WO2014142760A3 (en) | Re-trafficking of herg reverses long qt syndrome 2 phenotype in human ips-derived cardiomyocytes |